In cholangiocarcinoma, aberrant expression of H19 has been shown to promote proliferation and invasion through inflammatory and oxidative stress pathways in vitro (Wang et al., 2016; Xu et al., 2017a; Yu et al., 2020a). The gene discussed is H19; the disease is cholangiocarcinoma.